Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 13/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | RAF1 | P04049 | 2/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | LSS | P48449 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4282822 | 0.84 | RORC (0.41) | MAP4K4PARP10MEN1KMT2AEPHX2 | |
| SCHEMBL4283882 | 0.82 | PARP10 (0.43) | MAP4K4PARP10MEN1KMT2AEPHX2 | |
| SCHEMBL4283897 | 0.82 | HPGD (0.54) | PARP10MEN1KMT2ARAF1 | |
| SCHEMBL4289278 | 0.81 | MAPT (0.51) | PARP10KMT2A | |
| SCHEMBL4279745 | 0.80 | PARP10 (0.39) | MAP4K4PARP10MEN1KMT2AEPHX2 | |
| SCHEMBL4294425 | 0.73 | EPHX2 (0.51) | MAP4K4PARP10MEN1KMT2AEPHX2 | |
| SCHEMBL4285685 | 0.73 | EPHX2 (0.50) | MAP4K4PARP10MEN1KMT2AEPHX2 | |
| SCHEMBL24799517 | 0.69 | PARP10 (0.54) | MAP4K4PARP10EPHX2FAAHSENP8 | |
| SCHEMBL10313059 | 0.69 | ELANE (0.60) | PARP10MEN1KMT2AEPHX2FAAH | |
| SCHEMBL25106987 | 0.69 | LMNA (0.46) | MAP4K4PARP10MEN1KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2048150-A1 | BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | MAP4K4 1470/4885PARP10 2557/4885MEN1 3776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.